Clinical Trial Record

Return to Clinical Trials

Tight Glycemic Control by Artificial Pancreas


2007-04


2007-12


2007-12


32

Study Overview

Tight Glycemic Control by Artificial Pancreas

This study evaluated a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.

This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.

  • Pancreatic Neoplasm
  • DEVICE: Artificial Pancreas (STG-22)
  • TGC-AP-01

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2008-04-04  

N/A  

2008-04-08  

2008-04-08  

N/A  

2008-04-14  

2008-04-14  

N/A  

2008-04  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Treatment


Allocation:
Randomized


Interventional Model:
Single Group


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: 2

Thirty patients who underwent pancreatic resection for pancreatic neoplasm were prospectively randomized. Perioperative blood glucose levels were continuously monitored using an artificial endocrine pancreas (STG-22). Glucose levels were controlled using

DEVICE: Artificial Pancreas (STG-22)

  • safe tool
Primary Outcome MeasuresMeasure DescriptionTime Frame
the incidence of severe hypoglycemia (< 40 mg/dl) during the intensive care period following pancreatic resection in patients monitored using the artificial pancreasthe first postoperative 18 hours in the surgical intensive care unit
Secondary Outcome MeasuresMeasure DescriptionTime Frame
the total amount of insulin required for glycemic control after pancreatic resectionthe first postoperative 18 hours in the surgical intensive care unit

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.

  • Exclusion Criteria:

  • weight loss greater than 10% during the previous 6 months
  • signs of distant metastasis
  • respiratory, renal,or heart disease
  • Patients provided written informed consent prior to enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • STUDY_DIRECTOR: Takehiro Okabayashi, MD, Kochi Medical School, Kochi University

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available